131 related articles for article (PubMed ID: 833730)
1. Application of salivary concentration data to pharmacokinetic studies with antipyrine.
Meffin PJ; Williams RL; Blaschke TF; Rowland M
J Pharm Sci; 1977 Jan; 66(1):135-7. PubMed ID: 833730
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
Harman AE; Priestly BG; Frewin DB
Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
[TBL] [Abstract][Full Text] [Related]
3. Elimination of antipyrine from saliva as a measure of metabolism in man.
Welch RM; DeAngelis RL; Wingfield M; Farmer TW
Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
van Boxtel CJ; Wilson JT; Lindgren S; Sjöqvist F
Eur J Clin Pharmacol; 1976 Feb; 9(4):327-32. PubMed ID: 971716
[TBL] [Abstract][Full Text] [Related]
5. Assessment of antipyrine kinetics by measurement in saliva.
Fraser HS; Mucklow JC; Murray S; Davies DS
Br J Clin Pharmacol; 1976 Apr; 3(2):321-5. PubMed ID: 973966
[TBL] [Abstract][Full Text] [Related]
6. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
[TBL] [Abstract][Full Text] [Related]
7. Saliva and plasma clearance of antipyrine as reflectors of liver function.
Luoma PV; Sotaniemi EA
Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
[TBL] [Abstract][Full Text] [Related]
8. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
10. Assessment of antipyrine kinetics from saliva or plasma: influence of age.
Jorquera F; Almar MM; Jimeno A; González-Sastre M; González-Gallego J
J Pharm Biomed Anal; 1995 Aug; 13(9):1141-5. PubMed ID: 8573640
[TBL] [Abstract][Full Text] [Related]
11. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
[TBL] [Abstract][Full Text] [Related]
12. Antipyrine metabolism in patients with diabetes mellitus.
Murali KV; Adithan C; Shashindran CH; Gambhir SS; Chandrasekar S
Clin Exp Pharmacol Physiol; 1983; 10(1):7-13. PubMed ID: 6839551
[TBL] [Abstract][Full Text] [Related]
13. Salivary antipyrine half-life during injectable progestagen contraception.
Joshi JV; Gupta KC; Hazari KT; Gokral J; Pohujani S; Satoskar R
Clin Pharmacokinet; 1986; 11(2):171-5. PubMed ID: 3956050
[TBL] [Abstract][Full Text] [Related]
14. Antipyrine clearance in children from single saliva samples.
Loft S; Haxholdt O; Døssing M
Br J Clin Pharmacol; 1985 May; 19(5):698-700. PubMed ID: 4005107
[TBL] [Abstract][Full Text] [Related]
15. Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump.
Teunissen MW; Kleinbloesem CH; de Leede LG; Breimer DD
Eur J Clin Pharmacol; 1985; 28(6):681-4. PubMed ID: 4065192
[TBL] [Abstract][Full Text] [Related]
16. The effect of fever on antipyrine metabolism in children.
Forsyth JS; Moreland TA; Rylance GW
Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111
[TBL] [Abstract][Full Text] [Related]
17. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
Shaw PN; Houston JB; Rowland M; Hopkins K; Thiercelin JF; Morselli PL
Br J Clin Pharmacol; 1985 Dec; 20(6):611-8. PubMed ID: 4091993
[TBL] [Abstract][Full Text] [Related]
18. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.
Denlinger CL; Stryker KK; Slusher LB; Vesell ES
Clin Pharmacol Ther; 1987 May; 41(5):522-30. PubMed ID: 3568537
[TBL] [Abstract][Full Text] [Related]
19. Altered elimination of antipyrine in patients with acute viral hepatitis.
Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
[TBL] [Abstract][Full Text] [Related]
20. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD
Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
